Akari Therapeutics, Plc
AKTX
$10.93
-$0.03-0.27%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
1/17/2026
-
MarketBeat
9/8/2026
-
Globe Newswire
8/27/2026
-
The Cerbat Gem
8/27/2026
-
Globe Newswire
JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs
8/27/2026
-
ACCESS Newswire
8/24/2026
-
The Cerbat Gem
8/19/2026
-
TipRanks
8/18/2026
-
TipRanks: TheFly
8/18/2026
-
Globe Newswire
8/17/2026
-
The Cerbat Gem
8/14/2026
-
Seeking Alpha - Healthcare
8/13/2026
-
Globe Newswire
8/11/2026
-
The Cerbat Gem
8/4/2026
-
Globe Newswire
7/22/2026
-
Globe Newswire
7/21/2026
-
TipRanks: TheFly
7/21/2026
-
Globe Newswire
7/20/2026
-
The Cerbat Gem
7/20/2026
-
The Cerbat Gem
7/20/2026
-
TipRanks: TheFly
7/20/2026
-
TipRanks: TheFly
7/7/2026
-
TipRanks
7/7/2026
-
Globe Newswire
7/6/2026
-
TipRanks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
929 274 7510
Address
401 East Jackson Street
Suite 3300
Tampa, FL 33602
Suite 3300
Tampa, FL 33602
Country
Year Founded
--
Business Description
Sector
Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an...
more